IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i23p16373-d995512.html
   My bibliography  Save this article

Experience of Pharmacists with Anti-Cancer Medicine Shortages in Pakistan: Results of a Qualitative Study

Author

Listed:
  • Sundus Shukar

    (Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China)

  • Fatima Zahoor

    (Jeffrey Cheah School of Medicine and Health Sciences, Monash University, Bandar Sunway 47500, Malaysia)

  • Sumaira Omer

    (Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China)

  • Sundas Ejaz Awan

    (Faculty of Pharmacy, Gadjah Mada University, Yogyakarta 55281, Indonesia)

  • Caijun Yang

    (Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China)

  • Yu Fang

    (Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China)

Abstract

This study aimed to examine the current situation of anti-cancer drug shortages in Pakistan, namely its determinants, impacts, adopted mitigation strategies, and proposed solutions. Qualitative semi-structured, in-depth interviews were conducted with 25 pharmacists in oncology hospitals in Pakistan from August to October 2021. Data were collected in person and online, recorded, and subjected to inductive thematic analysis after being transcribed verbatim. Most participants experienced anti-cancer drug shortages that increased during the pandemic. Etoposide, paclitaxel, vincristine, dacarbazine, and methotrexate were frequently short. Important causes included the compromised role of regulatory authorities, lack of local production, and inventory mismanagement. The impacts were delayed/suboptimal treatment and out-of-pocket costs for patients, patients’ prioritization, increased workload, negative work environment, and patients’ trust issues for pharmacists. The participants proposed that a cautious regulator’s role is needed to revise policies for all stakeholders and support all stakeholders financially at their level to increase access to these medicines. Based on the outcomes, it is clear that anti-cancer medicine shortages are a current issue in Pakistan. Governmental authorities need to play a role in revising policies for all levels of the drug supply chain and promoting local production of these drugs. Stakeholders should also collaborate and manage inventory.

Suggested Citation

  • Sundus Shukar & Fatima Zahoor & Sumaira Omer & Sundas Ejaz Awan & Caijun Yang & Yu Fang, 2022. "Experience of Pharmacists with Anti-Cancer Medicine Shortages in Pakistan: Results of a Qualitative Study," IJERPH, MDPI, vol. 19(23), pages 1-12, December.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:23:p:16373-:d:995512
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/23/16373/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/23/16373/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Petronille Bogaert & Tomasz Bochenek & Anna Prokop & Andrzej Pilc, 2015. "A Qualitative Approach to a Better Understanding of the Problems Underlying Drug Shortages, as Viewed from Belgian, French and the European Union’s Perspectives," PLOS ONE, Public Library of Science, vol. 10(5), pages 1-20, May.
    2. Caijun Yang & Lina Wu & Wenfang Cai & Wenwen Zhu & Qian Shen & Zongjie Li & Yu Fang, 2016. "Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study," PLOS ONE, Public Library of Science, vol. 11(10), pages 1-16, October.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Saima Butt & Kamran Shaukat & Talha Mahboob Alam & Tony Jan, 2024. "Patents and Public Health: State Responsibility to Opt for a Balanced Approach," Societies, MDPI, vol. 14(8), pages 1-14, August.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Said, André & Goebel, Ralf & Ganso, Matthias & Zagermann-Muncke, Petra & Schulz, Martin, 2018. "Drug shortages may compromise patient safety: Results of a survey of the reference pharmacies of the Drug Commission of German Pharmacists," Health Policy, Elsevier, vol. 122(12), pages 1302-1309.
    2. Vogler, Sabine & Fischer, Stefan, 2020. "How to address medicines shortages: Findings from a cross-sectional study of 24 countries," Health Policy, Elsevier, vol. 124(12), pages 1287-1296.
    3. Caijun Yang & Wenfang Cai & Zongjie Li & Amy Theresa Page & Yu Fang, 2018. "The current status and effects of emergency drug shortages in China: Perceptions of emergency department physicians," PLOS ONE, Public Library of Science, vol. 13(10), pages 1-14, October.
    4. Chen, Xu & Yang, Huan & Wang, Xiaojun, 2019. "Effects of price cap regulation on the pharmaceutical supply chain," Journal of Business Research, Elsevier, vol. 97(C), pages 281-290.
    5. Zaprutko, Tomasz & Kopciuch, Dorota & Bronisz, Maria & Michalak, Michał & Kus, Krzysztof & Nowakowska, Elżbieta, 2020. "Drug shortages as a result of parallel export in Poland – Pharmacists’ opinions," Health Policy, Elsevier, vol. 124(5), pages 563-567.
    6. Yulei Zhu & Yuqin Ren & Hui Wang & Wenqing Fang & Xinglu Xu & Ying Wang & Huizhen Dai & Xin Li, 2022. "The impact of policy on availability and price of low‐price medicines in public healthcare institutions: A retrospective survey in Nanjing, China," International Journal of Health Planning and Management, Wiley Blackwell, vol. 37(2), pages 1118-1130, March.
    7. Asaeli Raikabakaba & Masoud Mohammadnezhad & Ledua Tamani & Devina Gaundan, 2022. "Drug Shortages and Its Effects on Service Delivery among Key Informants (KIs) in Fiji," Global Journal of Health Science, Canadian Center of Science and Education, vol. 14(5), pages 1-1, May.
    8. Rabie Mahssouni & Mohamed Noureddine Touijer & Mohamed Makhroute, 2022. "Employee Compensation, Training and Financial Performance during the COVID-19 Pandemic," JRFM, MDPI, vol. 15(12), pages 1-19, November.
    9. Caijun Yang & Lina Wu & Wenfang Cai & Wenwen Zhu & Qian Shen & Zongjie Li & Yu Fang, 2016. "Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study," PLOS ONE, Public Library of Science, vol. 11(10), pages 1-16, October.
    10. Josephine Walker & Betty B Chaar & Numa Vera & Alvish S Pillai & Jessy S Lim & Lisa Bero & Rebekah J Moles, 2017. "Medicine shortages in Fiji: A qualitative exploration of stakeholders’ views," PLOS ONE, Public Library of Science, vol. 12(6), pages 1-16, June.
    11. Jun Li & Di (Andrew) Wu, 2022. "The Price Effect of Drug Price Ceilings: Intended and Unintended Consequences," Management Science, INFORMS, vol. 68(8), pages 5758-5777, August.
    12. Kati Heiskanen & Riitta Ahonen & Risto Kanerva & Pekka Karttunen & Johanna Timonen, 2017. "The reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland," PLOS ONE, Public Library of Science, vol. 12(6), pages 1-14, June.
    13. Xiaojie Yang & Li Liu & Yi Zheng & Xue Yang & Shanlin Sun, 2022. "Pricing Problems in the Pharmaceutical Supply Chain with Mixed Channel: A Power Perspective," Sustainability, MDPI, vol. 14(12), pages 1-20, June.
    14. András Fittler & Róbert György Vida & Valter Rádics & Lajos Botz, 2018. "A challenge for healthcare but just another opportunity for illegitimate online sellers: Dubious market of shortage oncology drugs," PLOS ONE, Public Library of Science, vol. 13(8), pages 1-17, August.
    15. Emily Chen & Susan Goold & Sam Harrison & Iman Ali & Ibtihal Makki & Stanley S Kent & Andrew G Shuman, 2021. "Drug shortage management: A qualitative assessment of a collaborative approach," PLOS ONE, Public Library of Science, vol. 16(4), pages 1-13, April.
    16. Tinne Gils & Claire Bossard & Kristien Verdonck & Philip Owiti & Ilse Casteels & Maria Mashako & Gilles Van Cutsem & Tom Ellman, 2018. "Stockouts of HIV commodities in public health facilities in Kinshasa: Barriers to end HIV," PLOS ONE, Public Library of Science, vol. 13(1), pages 1-12, January.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:23:p:16373-:d:995512. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.